HOLX - Hologic FQ3 revenues up 3%; ytd cash flow down 20% July, 31 2019 04:43 PM Hologic Inc. Hologic (NASDAQ:HOLX) fiscal Q3 results (): Revenues: 852.4 (+3.4%); Diagnostics: 305.4 (+3.8%); Breast Health: 325.4 (+5.7%).More news on: Hologic, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...